MAOIs: Intro & MOA - Enzyme Blockers
- Monoamine Oxidase (MAO): Mitochondrial enzymes that catabolize monoamine neurotransmitters.
- MAO-A: Metabolizes Serotonin (5-HT), Norepinephrine (NE), Dopamine (DA), Tyramine. Found in brain, gut, liver.
- MAO-B: Metabolizes Dopamine (DA), Tyramine, Phenylethylamine. Found in brain, platelets.
- Mechanism of Action (MOA): MAOIs inhibit MAO enzyme activity, leading to ↑ intraneuronal concentrations of 5-HT, NE, and DA.
- Irreversible: Form stable covalent bonds (e.g., Phenelzine). Effect lasts ~2 weeks.
- Reversible (RIMA): Bind non-covalently (e.g., Moclobemide for MAO-A). Shorter duration of action.

⭐ MAO-A primarily metabolizes serotonin and norepinephrine; MAO-B primarily metabolizes dopamine and phenylethylamine.
MAOIs: Classification & Drugs - The Lineup
MAOIs: Classified by MAO-A/B selectivity & reversibility.
| Drug | Type | Reversibility | Key Notes |
|---|---|---|---|
| Phenelzine | Non-selective (A+B) | Irreversible | 📌 'PIT' group (Phenelzine, Isocarboxazid, Tranylcypromine) |
| Isocarboxazid | Non-selective (A+B) | Irreversible | |
| Tranylcypromine | Non-selective (A+B) | Irreversible | Amphetamine-like structure |
| Selegiline | Selective MAO-B | Irreversible | Parkinson's; dose-dependent selectivity |
| Rasagiline | Selective MAO-B | Irreversible | Parkinson's; potent |
| Moclobemide | Selective MAO-A (RIMA) | Reversible | Safer profile; less cheese reaction |
| Brofaromine | Selective MAO-A (RIMA) | Reversible | Limited use |
MAOIs: Clinical Uses & PK - When & How
- Clinical Uses:
- Atypical Depression (core indication, often with mood reactivity)
- Treatment-Resistant Depression (TRD)
- Anxiety Disorders: Panic disorder, Social phobia
- Parkinson's Disease (adjunctive with L-DOPA; MAO-B specific: Selegiline, Rasagiline)
- Pharmacokinetics (PK):
- Oral absorption: Generally good.
- Metabolism: Hepatic; e.g., Phenelzine via acetylation (genetic variability).
- Duration: Irreversible MAOIs have a long duration; enzyme regeneration takes ~2 weeks (crucial for washout).
⭐ MAOIs are particularly effective for atypical depression characterized by hypersomnia, hyperphagia, leaden paralysis, and rejection sensitivity.
MAOIs: Adverse Effects & CIs - Danger Zone
- Common Side Effects:
- Postural hypotension (most common)
- Weight gain
- Sexual dysfunction
- Insomnia, edema
- Anticholinergic effects (less common)
- ⚠️ Hypertensive Crisis ('Cheese Reaction'):
- Interaction with tyramine-rich foods (aged cheese, cured meats, red wine).
- Symptoms: Severe headache, hypertension, tachycardia.
⭐ The 'Cheese Reaction' is a medical emergency requiring immediate BP management, often with phentolamine.
- ⚠️ Serotonin Syndrome:
- Risk with serotonergic agents (SSRIs, triptans).
- Symptoms: Hyperthermia, muscle rigidity, myoclonus, autonomic instability, mental status changes.
- Contraindications:
- Pheochromocytoma
- Severe liver disease
- Significant cardiovascular disease (CHF, recent MI)
- Concomitant use of: sympathomimetics, other MAOIs, TCAs, SSRIs, SNRIs, meperidine, dextromethorphan.

MAOIs: Drug Interactions - Mixer Mayhem
- Food (Tyramine "Cheese Reaction"):
- Avoid: Aged cheese, cured/fermented meats, red wine, beer, soy.
- Risk: Hypertensive crisis.
- Drug Interactions (Potentially Fatal):
- Serotonin Syndrome: SSRIs, SNRIs, TCAs, pethidine, dextromethorphan.
- Hypertensive Crisis: Sympathomimetics (e.g., pseudoephedrine, amphetamines).
- Washout Period:
- General: 2 weeks before/after antidepressants.
- Fluoxetine: 5 weeks (long half-life).
⭐ A washout period of at least 14 days is crucial when switching to/from MAOIs to prevent serious interactions.
High‑Yield Points - ⚡ Biggest Takeaways
- Irreversibly inhibit MAO-A & MAO-B, ↑ levels of serotonin, norepinephrine, dopamine.
- Used for atypical depression and resistant depression; examples: Phenelzine, Tranylcypromine.
- Hypertensive crisis ("cheese reaction") with tyramine-rich foods (aged cheese, red wine) is a critical adverse effect.
- Risk of Serotonin Syndrome with SSRIs, TCAs, pethidine; requires a 2-week washout period (5 weeks for fluoxetine).
- Moclobemide (RIMA) is reversible, with lower risk of cheese reaction. Selegiline is MAO-B selective for Parkinson's disease at low doses.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app